Biallelic BORCS8 variants cause an infantile-onset neurodegenerative disorder with altered lysosome dynamics.

hereditary spastic paraplegia leukodystrophy lysosomes neurodegeneration neurodevelopmental disorder

Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
21 Dec 2023
Historique:
received: 11 04 2022
revised: 30 09 2023
accepted: 02 12 2023
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 21 12 2023
Statut: aheadofprint

Résumé

BLOC-One-Related Complex (BORC) is a multiprotein complex composed of eight subunits named BORCS1-8. BORC associates with the cytosolic face of lysosomes, where it sequentially recruits the small GTPase ARL8 and kinesin-1 and -3 microtubule motors to promote anterograde transport of lysosomes toward the peripheral cytoplasm in non-neuronal cells and the distal axon in neurons. The physiological and pathological importance of BORC in humans, however, remains to be determined. Here, we report the identification of compound heterozygous variants [missense c.85T > C (p.Ser29Pro) and frameshift c.71-75dupTGGCC (p.Asn26Trpfs*51)] and homozygous variants [missense c.196A > C (p.Thr66Pro) and c.124T > C (p.Ser42Pro)] in BORCS8 in five children with a severe early-infantile neurodegenerative disorder from three unrelated families. The children exhibit global developmental delay, severe-to-profound intellectual disability, hypotonia, limb spasticity, muscle wasting, dysmorphic facies, optic atrophy, leuko-axonopathy with hypomyelination, and neurodegenerative features with prevalent supratentorial involvement. Cellular studies using a heterologous transfection system show that the BORCS8 missense variants p.Ser29Pro, p.Ser42Pro and p.Thr66Pro are expressed at normal levels but exhibit reduced assembly with other BORC subunits and reduced ability to drive lysosome distribution toward the cell periphery. The BORCS8 frameshift variant p.Asn26Trpfs*51, on the other hand, is expressed at lower levels and is completely incapable of assembling with other BORC subunits and promoting lysosome distribution toward the cell periphery. Therefore, all the BORCS8 variants are partial or total loss-of-function alleles and are thus likely pathogenic. Knockout of the orthologous borcs8 in zebrafish causes decreased brain and eye size, neuromuscular anomalies and impaired locomotion, recapitulating some of the key traits of the human disease. These findings thus identify BORCS8 as a novel genetic locus for an early-infantile neurodegenerative disorder and highlight the critical importance of BORC and lysosome dynamics for the development and function of the central nervous system.

Identifiants

pubmed: 38128568
pii: 7490825
doi: 10.1093/brain/awad427
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Published by Oxford University Press on behalf of the Guarantors of Brain 2023.

Auteurs

Raffaella De Pace (R)

Neurosciences and Cellular and Structural Biology Division, Eunice Kennedy Shiver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

Reza Maroofian (R)

UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.

Adeline Paimboeuf (A)

INRS - Centre Armand Frappier Santé Biotechnologie, Laval, QC H7 V 1B7, Canada.

Mina Zamani (M)

Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, 83151-61355, Iran.
Narges Medical Genetics and Prenatal Diagnosis Laboratory, Kianpars, Ahvaz, 61556-89467, Iran.

Maha S Zaki (MS)

Human Genetics and Genome Research Division, Clinical Genetics Department, National Research Centre, Cairo, 12622, Egypt.

Saeid Sadeghian (S)

Department of Pediatric Neurology, Golestan Medical, Educational, and Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, 61357-33184, Iran.

Reza Azizimalamiri (R)

Department of Pediatric Neurology, Golestan Medical, Educational, and Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, 61357-33184, Iran.

Hamid Galehdari (H)

Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, 83151-61355, Iran.

Jawaher Zeighami (J)

Narges Medical Genetics and Prenatal Diagnosis Laboratory, Kianpars, Ahvaz, 61556-89467, Iran.

Chad D Williamson (CD)

Neurosciences and Cellular and Structural Biology Division, Eunice Kennedy Shiver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

Emily Fleming (E)

Department of Genetics, Children's Mercy Kansas City, Kansas City, MO 64108, USA.

Dihong Zhou (D)

Department of Genetics, Children's Mercy Kansas City, Kansas City, MO 64108, USA.
Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.

Jennifer L Gannon (JL)

Department of Pediatrics, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.
Division of Clinical Genetics, Children's Mercy Kansas City, Kansas City, MO 64108, USA.

Isabelle Thiffault (I)

Department of Genetics, Children's Mercy Kansas City, Kansas City, MO 64108, USA.
Department of Pathology, Children's Mercy Kansas City, Kansas City, MO 64108, USA.

Emmanuel Roze (E)

Sorbonne Université, CNRS, INSERM, Institut du Cerveau (ICM), and Assistance Publique-Hôpitaux de Paris, Hôpital de la Pitié-Salpêtrière, Paris, 75013, France.

Mohnish Suri (M)

Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.

Giovanni Zifarelli (G)

CENTOGENE GmbH, Am Strande 7, 18055 Rostock, Germany.

Peter Bauer (P)

CENTOGENE GmbH, Am Strande 7, 18055 Rostock, Germany.

Henry Houlden (H)

UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.

Mariasavina Severino (M)

Neuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genoa, 16147, Italy.

Shunmoogum A Patten (SA)

INRS - Centre Armand Frappier Santé Biotechnologie, Laval, QC H7 V 1B7, Canada.
Departement de Neurosciences, Université de Montréal, QC H3C 3J7, Canada.

Emily Farrow (E)

Department of Genetics, Children's Mercy Kansas City, Kansas City, MO 64108, USA.
Genomic Medicine Center, Children's Mercy Kansas City, Kansas City, MO 64108, USA.

Juan S Bonifacino (JS)

Neurosciences and Cellular and Structural Biology Division, Eunice Kennedy Shiver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

Classifications MeSH